Protein G, protein A and protein A-derived peptides inhibit the agitation induced aggregation of IgG

Molecular Pharmaceutics

Volumn 9, Issue 3, 2012, Pages 622-628

  Zhang, Jun ^a   Topp, Elizabeth M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

aggregation; biologics; IgG; peptide library; protein A; protein formulation; protein G

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; PEPTIDE DERIVATIVE; PROTEIN A; PROTEIN G;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; IMMUNOGLOBULIN AGGREGATE; LIGAND BINDING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; ULTRAVIOLET SPECTROSCOPY;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOGLOBULIN G; PEPTIDES; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; STAPHYLOCOCCAL PROTEIN A;

EID: 84863234160     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200548x     Document Type: Article

References (24)

1. ElBakri, A.; Nelson, P. N.; Abu Odeh, R. O. The state of antibody therapy Hum. Immunol. 2010, 71 (12) 1243-1250
2. Pavlou, A. K.; Belsey, M. J. The therapeutic antibodies market to 2008 Eur. J. Pharm. Biopharm. 2005, 59 (3) 389-396 (Pubitemid 40342513)
3. Reichert, J. M. Monoclonal antibodies as innovative therapeutics Curr. Pharm. Biotechnol. 2008, 9, 423-430
4. Huang, C. J.; Lowe, A. J.; Batt, C. A. Recombinant immunotherapeutics: Current state and perspectives regarding the feasibility and market Appl. Microbiol. Biotechnol. 2010, 87, 401-410
5. Li, J.; Zhu, Z. Research and development of next generation of antibody-based therapeutics Acta Pharmacol. Sin. 2010, 31, 1198-1207
6. Chi, E. Y.; Krishnan, S.; Randolph, T. W.; Carpenter, J. F. Physical stability of proteins in aqueous solution: Mechanism and drving forces in nonnative protein aggregation Pharm. Res. 2003, 20 (9) 1325-1336 (Pubitemid 37164039)
7. Serno, T.; Carpenter, J. F.; Randolph, T. W.; Winter, G. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta- cyclodextrin J. Pharm. Sci. 2010, 99 (3) 1193-1206
8. Chennamsetty, N.; Voynov, V.; Kayser, V.; Helk, F.; Trout, B. L. Design of therapeutic proteins with enhanced stability Proc. Natl. Acad. Sci. U.S.A. 2009, 29, 11937-11942
9. Teilum, K.; Olsen, J. G.; Kragelund, B. B. Protein stability, flexibility and function Biochim. Biophys. Acta 2011, 1814, 969-976
10. Sanchez-Ruiz, J. M. Ligand effects on protein thermodynamic stability Biophys. Chem. 2007, 126, 43-49 (Pubitemid 46186638)
11. Roque, A. C. A.; Silva, C. S. O.; Taipa, M. A. Affinity-based methodologies and ligands for antibody purification: Advances and perspectives J. Chromatogr., A 2007, 1160, 44-55 (Pubitemid 47078947)
12. DeLano, W. L.; Ultsch, M. H.; de Vos, A. M.; Wells, J. A. Convergent solutions to binding at a protein-protein interface Science 2000, 287, 1279-1283 (Pubitemid 30112152)
13. Katayama, D. S.; Nayar, R.; Chou, D. K.; Campos, J.; Cooper, J.; Vander Velde, D. G.; Villarete, L.; Liu, C. P.; Manning, M. C. Solution behavior of a novel type 1 interferon, interferon-tau J. Pharm. Sci. 2005, 94 (12) 2703-2715 (Pubitemid 43265393)
14. Hawe, A.; Kasper, J. C.; Friess, W.; Jiskoot, W. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress Eur. J. Pharm. Sci. 2009, 38 (2) 79-87
15. Zhang, J.; Wu, X.; Padovani, D.; Schubert, H. L.; Gravel, R. A. Ligand-binding by catalytically inactive mutants of the cbIB complementation group defective in human ATP:cob(I)alamin adenosyltransferase Mol. Genet. Metab. 2009, 98 (3) 278-284
16. Chowdhury, S.; Banerjee, R. Role of the dimethylbenzimidazole tail in the reaction catalyzed by coenzyme B12-dependent methylmalonyl-CoA mutase Biochemistry 1999, 38 (46) 15287-15294 (Pubitemid 129520362)
17. He, F.; Woods, C. E.; Litowski, J. R.; Roschen, L. A.; Gadgil, H. S.; Razinkov, V. I.; Kerwin, B. A. Effect of sugar molecules on the viscosity of high concentration monoclonal antibody solutions Pharm. Res. 2011, 28 (7) 1552-1560
18. Froese, D. S.; Healy, S.; McDonald, M.; Kochan, G.; Oppermann, U.; Niesen, F. H.; Gravel, R. A. Thermolability of mutant MMACHC protein in the vitamin B12-responsive cblC disorder Mol. Genet. Metab. 2010, 100 (1) 29-36
19. Niesen, F. H.; Berglund, H.; Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability Nat. Protoc. 2007, 2 (9) 2212-2221 (Pubitemid 351565860)
20. Deisenhofer, J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of Protein A from Staphylococcus aureus at 2.9- and 2.8-angstrom resolution Biochemistry 1981, 20 (9) 2361-2370 (Pubitemid 11089772)
21. Matulis, D.; Kranz, J. K.; Salemme, F. R.; Todd, M. J. Thermodynamic stability of carbonic anhydrase: Measurements of binding affinity and stoichiometry using ThermoFluor Biochemistry 2005, 44 (13) 5258-5266 (Pubitemid 40471238)
22. Vedadi, M.; Niesen, F. H.; Allali-Hassani, A.; Fedorov, O. Y.; Finerty, P. J.; Wasney, G. A.; Yeung, R.; Arrowsmith, C.; Ball, L. J.; Berglund, H.; Hui, R.; Marsden, B. D.; Nordlund, P.; Sundstrom, M.; Weigelt, J.; Edwards, A. M. Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (43) 15835-15840 (Pubitemid 44657553)
23. Sauer-Eriksson, A. E.; Kleywegt, G. J.; Uhlen, M.; Jones, T. A. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG Structure 1995, 3, 265-278
24. Rispens, T.; Himly, M.; Ooievaar-De Heer, P.; den Bleker, T. H.; Aalberse, R. C. Traces of pFc′ in IVIG interact with human IgG Fc domains and counteract aggregation Eur. J. Pharm. Sci. 2010, 40, 62-68